Who does Totally plc serve among overstretched UK and Irish public health systems?
Totally plc targets government-funded healthcare providers, offering capacity solutions where waiting times breach targets. In 2025 the NHS recorded persistent elective backlogs, confirming steady demand for outsourced capacity.
Public health trusts and health ministries buy block contracts and spot capacity; procurement cycles drive revenue predictability and policy risk. See Totally SWOT Analysis.
Who Is Totally Really Trying to Reach?
Totally plc targets institutional payers and end users: NHS bodies and Irish health trusts for multi-year contracts, plus corporates, private insurers, and self-pay patients; patient users skew to families with children, adults 35-75, and those 65+.
Main customer group: NHS and Irish public health purchasers
Totally Company clients are primarily B2G and B2B buyers: NHS England and Wales, Integrated Care Boards (ICBs), NHS Trusts, HSE and Saolta Group in Ireland, procuring 2-5 year contracts often worth £3m-£25m per annum per award.
Secondary customer groups: corporates and private patients
Totally Company target customers include occupational health buyers, private medical insurers, and growing self-pay patients in Ireland, providing enterprise solutions and services for healthcare providers and employers.
Customer type and market role
Totally plc serves a mixed base: institutional payers (B2G/B2B) for large contracted services and B2C end users for urgent and elective care delivery, with enterprise solutions for health systems and SMEs.
Most important segment by revenue
Public-sector contracts via NHS/ICBs and Irish trusts drive scale and revenue; these institutional awards generate the majority of annual income and strategic pipeline for multi-year delivery.
Core target: institutional health buyers and backlog patients
Totally Company serves institutional healthcare payers as its primary buyers while addressing end-user patients stuck in RTT backlogs and those needing urgent care; families, seniors, and adults 35-75 are clear user cohorts.
- Primary customers: NHS bodies, ICBs, NHS Trusts, HSE, Saolta Group
- Secondary buyers: corporates (occupational health), private insurers, self-pay patients
- Market mix: mainly B2B/B2G with significant B2C patient-facing services
- Most commercially important: public-sector contracts (2-5 year, £3m-£25m p.a.)
For context on strategic positioning and values see What Totally Company Stands For.
Totally SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Do Totally's Customers Care About?
Totally Company clients care most about reducing NHS waiting lists, meeting regulatory KPIs, and securing reliable, safe capacity to hit targets for elective care and urgent care flow.
Cut RTT and elective backlogs
Institutional payers want capacity to clear the 7.25 million RTT backlog (January 2026) and reach the 18 – week standard for elective treatment.
Practical buying drivers: capacity, speed, compliance
Payers choose providers who reliably shorten waits, reduce >52 – week waits, and improve A&E throughput to approach the four – hour target; cost per case and predictable scheduling matter most.
Emotional appeal: public accountability
Procurement teams need partners that lower political and reputational risk; delivering measurable KPI improvements reduces scrutiny and builds trust.
What customers value most: safety and measurability
Clients prioritize proven clinical governance-Totally plc's consistent CQC Good ratings-plus trackable outcomes tied to RTT, four – hour A&E performance, and >52 – week reductions.
Loyalty drivers: consistent KPI delivery
Repeat contracts follow when suppliers deliver year – on – year reductions in waiting lists, steady compliance with standards, and transparent reporting for commissioners.
Why customers choose Totally Company
Totally Company target customers select it for fast, regulated capacity provision backed by CQC Good ratings and a track record of reducing RTT and A&E pressure; see how it sells in this article: How Totally Company Sells
What Those Customers Care About
Institutional payers-especially NHS commissioners-need immediate, measurable capacity to cut the 7.25 million RTT backlog (Jan 2026), meet the 18 – week elective standard, reduce >52 – week waits, and ease A&E so four – hour targets improve; safety, CQC assurance, and transparent reporting drive procurement decisions.
- Reduce RTT backlog and >52 – week waits
- Reliable, timely capacity to hit 18 – week and four – hour targets
- Lower political and reputational risk through compliant partners
- CQC – rated safety and measurable KPI delivery win contracts
Totally PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Where Is Demand Strongest for Totally?
Demand for Totally plc is strongest in the UK and Ireland, concentrated in urgent care corridors and regions with the highest throughput pressures; elective insourcing in high-throughput diagnostics also shows rapid growth.
Main UK and Ireland urgent-care corridors
Totally Company clients cluster in the UK and Ireland, especially NHS 111, Urgent Treatment Centres, and GP out-of-hours networks where call volumes and clinical assessments are highest.
Elective diagnostics and insourcing verticals
Secondary demand comes from elective insourcing in endoscopy, ophthalmology, dermatology, orthopaedics, and ENT, driven by an estimated £2 billion to £3 billion annual outsourced diagnostics and insourcing market in the UK.
Where Totally Company is strongest
Totally Company target customers include NHS contracts where the firm often ranks top-two by call volume and clinical assessments in contracted regions, with particularly deep reach in the North of England and Ireland.
Fastest-growing demand areas (2025-2026)
Demand is growing fastest for higher-margin elective insourcing and outsourced diagnostics in high-throughput specialties; adoption rose materially in 2024-2025 as NHS backlogs widened.
Concentration of demand for Totally Company
Most demand is concentrated in NHS urgent-care corridors in the UK and Ireland, and increasingly in elective insourcing specialties where outsourced diagnostics spending totals about £2-3bn annually.
- UK and Ireland urgent-care corridors (NHS 111, UTCs, GP out-of-hours)
- Elective insourcing in endoscopy, ophthalmology, dermatology, orthopaedics, ENT
- Strongest presence in the North of England and Ireland; top-two provider by call volume in many contracted regions
- Future growth: elective diagnostics and insourcing across NHS backlog management
For market positioning and competitor context see Who Totally Company Competes With
Totally SOAR Analysis
- Complete SOAR Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
How Does Totally Keep Its Audience Growing?
Totally plc grows its audience by shifting from pandemic-volume tactics to high-margin specialist elective services, securing long-term NHS and regional frameworks, and expanding private-pay bundles to retain and reach adjacent patient segments.
Expanding Patient and Buyer Segments
Totally plc adds new patients and institutional buyers by targeting 15-25 percent year-on-year growth in elective procedure volumes (cataract, endoscopy) to address the RTT backlog, and by pursuing regional frameworks in Ireland and long-term contracts rather than one-off projects. See Where Totally Company Is Going for context on strategy shifts after the June 9, 2025 acquisition.
Customer Retention Drivers
Retention hinges on multi-year framework agreements with NHS trusts and integrated outsourced capacity under the NHS Urgent and Emergency Care Plan 2025/26, plus tech-driven productivity gains that lower per-case cost and improve service consistency.
Loyalty, Repeat Demand, and Depth
Repeat demand is driven by bundled private-pay offerings (cataracts, endoscopy) and placement in regional frameworks; predictable scheduling and outcome tracking increase referral frequency from primary care and hospital partners.
Strongest Growth Lever in 2025/2026
The key lever is long-term NHS and regional frameworks backed by the NHS Urgent and Emergency Care Plan 2025/26 funding, which converts outsourced capacity into a stable revenue baseline and supports scaling of higher-margin specialist services.
How It Keeps the Audience Growing
Totally plc sustains audience growth by converting backlog-driven demand into recurring, higher-margin elective workflows through long-term frameworks, private-pay bundles, and productivity-enhancing technology after its June 9, 2025 integration into PHL Group Ltd.
- Primary growth driver: 15-25 percent targeted annual procedure-volume growth for elective care
- Strongest retention factor: multi-year NHS/regional frameworks and integrated outsourced capacity under NHS 2025/26 plan
- Top loyalty mechanism: private-pay procedure bundles (cataracts, endoscopy) and predictable scheduling
- Main risk: reliance on public funding and framework awards tied to NHS policy and capital allocations
Totally VRIO Analysis
- Covers VRIO Analysis in Details
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What Does Totally Company Stand For?
- How Did Totally Company Become What It Is Today?
- Who Owns Totally Company and Why Does It Matter?
- How Does Totally Company Actually Work?
- How Does Totally Company Sell Its Products and Services?
- Where Is Totally Company Going Next?
- Who Does Totally Company Compete With?
Frequently Asked Questions
Totally mainly serves institutional healthcare buyers and end users. Its core customers are NHS bodies, Integrated Care Boards, NHS Trusts, HSE, and Saolta Group, while secondary groups include corporates, private insurers, and self-pay patients. The business mixes B2B and B2G contracts with patient-facing care delivery.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.